Immix Biopharma (IMMX) Tax Rate (2021 - 2026)
Immix Biopharma (IMMX) posted Tax Rate of 77.4% for Q4 2025, up 76053.78% sequentially from 0.1% in Q3 2025, and up 7733.0% YoY from 0.99% in Q4 2024.
Powered by 
Analysis
Immix Biopharma (IMMX) Tax Rate (2021 - 2026) Analysis & Trends
Immix Biopharma has reported Tax Rate for 5 years, with the latest figure at 77.4% in Q4 2025.
- Quarterly Tax Rate rose 7733.0% year-over-year to 77.4% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 28.02% (up 3068.0% YoY) and the FY2025 annual result came in at 28.02%, up 3068.0% from the prior year.
- Tax Rate grew to 77.4% in Q4 2025 per IMMX's latest filing, from 0.1% in the prior quarter.
- Over five years, Tax Rate peaked at 84.07% in Q4 2023 and troughed at 0.78% in Q2 2021.
- A 5-year average of 10.21% and a median of 0.15% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2024 and 2025: Tax Rate plunged 8400 bps in 2024, then soared 7733 bps in 2025.
- Over 5 years, Tax Rate stood at 0.01% in 2021, then soared by 707047 bps to 45.89% in 2022, then soared by 83 bps to 84.07% in 2023, then slumped by 100 bps to 0.07% in 2024, then jumped by 109796 bps to 77.4% in 2025.
- According to Business Quant data, Tax Rate over the past three periods registered 77.4%, 0.1%, and 0.13% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Immix Biopharma | 889.29 Mn | 889.29 Mn | - | -0.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12% |
| Dec 31, 2025 | 77.40% |
| Sep 30, 2025 | -0.10% |
| Jun 30, 2025 | -0.13% |
| Mar 31, 2025 | -0.22% |
| Dec 31, 2024 | 126.42% |
| Sep 30, 2024 | -0.16% |
| Jun 30, 2024 | -0.23% |
| Mar 31, 2024 | -0.17% |
| Dec 31, 2023 | 84.07% |
| Sep 30, 2023 | -0.16% |
| Jun 30, 2023 | -0.18% |
| Mar 31, 2023 | -0.21% |
| Dec 31, 2022 | 45.89% |
| Sep 30, 2022 | -0.11% |
| Jun 30, 2022 | -0.11% |
| Mar 31, 2022 | -0.12% |
| Dec 31, 2021 | 22.52% |
| Sep 30, 2021 | -0.33% |
| Jun 30, 2021 | -0.78% |